BeiGene abandons TIGIT antibody after lung cancer flop
BeiGene has decided to stop the development of its TIGIT-targeting drug ociperlimab in yet another setback for the drug class.
Multiple studies of Sarepta's DMD therapy halted after death
Three studies of Sarepta's Elevidys Duchenne gene therapy have been placed on hold as the death of a 16-year-old boy is investigated.
Germany will reimburse haemophilia gene therapy Hemgenix
Germany has agreed to reimburse CSL Behring's haemophilia B gene therapy Hemgenix with a 'unique' outcomes-based payment model.
Novartis gets FDA nod for second of three IgAN drugs
Novartis has claimed accelerated approval in the US for Vanrafia, one of a trio of drugs it hopes will revolutionise the treatment of IgA nephropathy.
Featured Content
Latest News
Views & Analysis
Deep Dive
White Papers & Webinar
Podcasts & Video
Partner Content
PM Society announces the launch of The PMi Awards 2025
After 15 years as the PM Society Digital Awards, and after taking feedback from our membership, this successful event has evolved its name and sharpened its focus on impact and innovation.
ISPE Singapore Affiliate Conference & Exhibition 2025
The ISPE Singapore Affiliate Conference & Exhibition is one of the largest and most respected events for bio & pharmaceutical manufacturing professionals.
The Home of Accelerating Microbiome R&D
10th Annual Microbiome Movement returns with many new & exciting features including...
Accelerating Breakthroughs in Immunodermatology Drug Develop...
Your Collaborative Forum to Shape the Future of Dermatology
Structure-Based Drug Design Summit Returns This June
With tightening budgets and increasing pressure to de-risk R&D, pharma and biotech are shifting their focus toward smarter, more efficient drug design.